The translocation results in the formation of a short chromosome 22, called the Philadelphia chromosome, and the generation of the BCR::ABL1 oncogene in almost all CML cases.1 The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.